A humanoid robot being escorted away by police in Macau has gone viral online, prompting jokes about what some called the world’s first “robot arrest.”
Updated
March 13, 2026 2:04 PM
Macau police officer accompanying the humanoid robot. PHOTO: THREADS@BOXOF_CHOCOLATE
Police in Macau recently detained a humanoid robot after it frightened an elderly woman on a public street. The unusual encounter quickly spread online, prompting jokes about what some called the world’s first “robot arrest”.
On the evening of March 5, the robot was taken away by officers after the encounter triggered alarm among bystanders. Videos circulating on social media show an elderly woman confronting the robot on a sidewalk, visibly distressed and shouting that her “heart is pounding” while demanding to know why such “nonsense” was happening on the street. In the clip, the robot raises both hands toward the woman after she lashes out in fear — a gesture many viewers interpreted as a sign of apology.
Shortly afterwards, two officers from the Macau Public Security Police Force were seen escorting the robot and a man believed to be its operator away from the area. An officer is seen placing his right hand on the robot’s shoulder — the same posture police often use when presenting arrested suspects in official photographs.
That scene quickly spread online, fuelling jokes about what some called the world’s first “robot arrest”.
Photos shared online show a humanoid robot with long limbs and exposed mechanical joints, built from a black metallic frame without an outer shell. In dim lighting, several commenters said it resembled a “moving skeleton” — a striking sight for pedestrians encountering it unexpectedly on the street.
Witnesses said the woman appeared severely shaken and an ambulance was eventually called to take her to the hospital.
The incident also sparked discussion online about robots operating in public spaces. Some commenters argued that experimental technologies should be tested in controlled environments, while others said machines moving through public areas should have clearer designs or safety measures to avoid alarming pedestrians.
It remains unclear who deployed the robot or what purpose it was serving in the area at the time of the incident. Authorities have not released further details about the device or whether any action was taken following the encounter.
Keep Reading
A new bet on early heart failure detection and why women’s health is at the center.
Updated
January 8, 2026 6:28 PM
A doctor holding an artificial heart model. PHOTO: ADOBE STOCK
Heart disease does not always announce itself clearly, especially in women. Many of the symptoms are ordinary, including fatigue, shortness of breath and swelling. These signs are frequently dismissed or explained away. As a result, many women are diagnosed late, when treatment options are narrower and outcomes are worse. That diagnostic gap is the context behind a recent investment involving Ultromics and the American Heart Association’s Go Red for Women Venture Fund.
Ultromics is a health technology company that uses artificial intelligence to help doctors spot early signs of heart failure from routine heart scans. It has received a strategic investment from the American Heart Association’s Go Red for Women Venture Fund.
The focus of the investment is a long-standing blind spot in cardiac care. Heart failure with preserved ejection fraction, or HFpEF, affects millions of people worldwide, with women disproportionately impacted. It is one of the most common forms of heart failure, yet also one of the hardest to diagnose. Studies even show women are twice as likely as men to develop the condition and around 64% of cases go undiagnosed in routine clinical practice.
Ultromics works with a tool most patients already experience during heart care: the echocardiogram. There is no new scan and no added burden for patients. Its software analyzes standard heart ultrasound images and looks for subtle patterns that point to early heart failure. The goal is clarity. Give clinicians better signals earlier, before the disease advances.
“Heart failure with preserved ejection fraction is one of the most complex and overlooked diseases in cardiology. For too long, clinicians have been expected to diagnose it using tools that weren't built to detect it and as a result, many patients are identified too late,” said Ross Upton, PhD, CEO and Founder of Ultromics. “By augmenting physicians' decision making with EchoGo, we can help them recognize disease at an earlier stage and treat it more effectively.”
The stakes are high. Research suggests women are twice as likely as men to develop the condition and that a majority of cases are missed in routine clinical practice. That delay matters. New therapies can reduce hospitalizations and improve survival, but only if patients are diagnosed in time.
This is why early detection has become a priority for mission-driven investors. “Closing the diagnostic gap by recognizing disease before irreversible damage occurs is critical to improving health for women—and everyone,” said Tracy Warren, Senior Managing Director, Go Red for Women Venture Fund. “We are gratified to see technologies, such as this one, that are accepted by leading institutions as advances in the field of cardiovascular diagnostics. That's the kind of progress our fund was created to accelerate.”
Ultromics’ platform is already cleared by regulators for clinical use and is being deployed in hospitals across the US and UK. The company says its technology has analyzed hundreds of thousands of heart scans, helping clinicians reach clearer conclusions when traditional methods fall short.
Taken together, the investment reflects a broader shift in healthcare. Attention is shifting earlier—toward detection instead of reaction. Toward tools that fit into existing care rather than complicate it. In this case, the funding is not about introducing something new into the system. It is about seeing what has long been missed—and doing so in time.